Article Listing

FDA News
Jan 14, 2020
The U.S. Food and Drug Administration (FDA) has approved Valtoco® (diazepam nasal spray). This is a new seizure medicine designed to treat periods of frequent seizures or cluster seizures that are distinct from the person’s usual seizure pattern....
Jackie French's photo with the world INNOVATOR
Jan 14, 2020
Dr. Jacqueline French is the chief medical and innovation officer at the Epilepsy Foundation. For the December 2019 issue of the Research Quarterly, I wanted to focus on the Research Roundtable for Epilepsy (RRE), which the Epilepsy Foundation...
Medication alert about recall
Jan 12, 2020
On January 10, 2020, the U.S. Food and Drug Administration (FDA) published a company alert about a voluntary recall of lamotrigine 100 mg tablets from Taro Pharmaceuticals. Lamotrigine 100 mg tablets from lot # 331771 are being recalled due to...
NACBHDD Webinar
Jan 11, 2020
Webinar on Thursday, February 6, 2020, 2:00 to 3:00 p.m. ET Register here Download the Webinar Flyer Feb 2020 Webinar on Cognitive Behavioral Therapy in Epilepsy   Please join us for a webinar hosted by the National Association of...
Doc.AI
Jan 6, 2020
Sam De Brouwer is the co-founder of doc.ai. Recently, doc.ai launched an epilepsy digital health trial to test how artificial intelligence (A.I.) might be able to help identify the right treatment for the right person at the right time. We sat down...

Our Mission

The mission of the Epilepsy Foundation is to lead the fight to overcome the challenges of living with epilepsy and to accelerate therapies to stop seizures, find cures, and save lives.

 
24/7 helpline